Analysis of 303 Ro/SS-A antibody-positive patients: is this antibody a possible marker for malignancy?BÖCKLE, B. C; STANAREVIC, G; RATZINGER, G et al.British journal of dermatology (1951). 2012, Vol 167, Num 5, pp 1067-1075, issn 0007-0963, 9 p.Article

Hepatitis C and autoimmunity: a therapeutic challengeBÖCKLE, B. C; BALTACI, M; RATZINGER, G et al.Journal of internal medicine. 2012, Vol 271, Num 1, pp 104-106, issn 0954-6820, 3 p.Article

CADASIL : an unusual manifestation with prominent cutaneous involvementRATZINGER, G; RANSMAYR, G; ROMANI, N et al.British journal of dermatology (1951). 2005, Vol 152, Num 2, pp 346-349, issn 0007-0963, 4 p.Article

Alteration of the glycosylation pattern of monocytic THP-1 cells upon differentiation and its impact on lectin-mediated drug deliveryPLATTNER, V. E; RATZINGER, G; ENGLEDER, E. T et al.European journal of pharmaceutics and biopharmaceutics. 2009, Vol 73, Num 3, pp 324-330, issn 0939-6411, 7 p.Article

Characterization of binding and uptake of biomimetic nanoparticles by flow cytometryGABOR, F; TRIMMEL, K; RATZINGER, G et al.Journal of drug delivery science and technology. 2008, Vol 18, Num 1, pp 51-57, 7 p.Article

Temozolomide and interferon α2b in metastatic melanoma stage IVRICHTIG, E; HOFMANN-WELLENHOF, R; KOLLER, J et al.British journal of dermatology (1951). 2004, Vol 151, Num 1, pp 91-98, issn 0007-0963, 8 p.Article